Regulatory News FDA final guidance on psychedelics opens the door to psycho-oncology researchGuidance permits treatment without psychotherapy, alarming scientists, advocates July 17, 2026Vol.52 No.28By Sara Willa Ernst
Regulatory News OMB proposal to sideline peer review sparks widespread oppositionNearly 500,000 public comments flood in—here are some highlights July 17, 2026Vol.52 No.28By Claire Marie Porter
Guest Editorial Cancer progress is not reaching everyone. Native Nations must be part of the solution. July 17, 2026Vol.52 No.28By Rodney Haring
Cancer Policy House Energy & Commerce hearing focuses on America’s leadership in biomedical research, examines FDA role July 17, 2026Vol.52 No.28By Claire Marie Porter
Cancer Policy White House regulatory priorities include “aggressive” HHS agenda July 17, 2026Vol.52 No.28By Jacquelyn Cobb
Cancer Policy HHS cancels fourth USPSTF meeting in a row July 17, 2026Vol.52 No.28By Claire Marie Porter
In Brief Dartmouth raises over $12M for cancer research at 45th annual Prouty fundraiser July 17, 2026Vol.52 No.28
In Brief LSU LCMC Health cancer center researchers receive $3.1M NIH grant to study pancreatic cancer July 17, 2026Vol.52 No.28
